soul trial oral semaglutide cardiovascular outcomes results 2024 2025 found to lower risk of heart failure events in people with type 2 diabetes SOUL Trial Shows Oral Semaglutide

It is not intended for human consumption, medical diagnosis, or therapeutic application

doi: 10.1016/j.bbcan.2021.188559 10 LiYShaZPengH

This is not the same product as Ozempic or Wegovy

I have been coming to iThriveMD ever since they opened up and I am obsessed

adult population using data from the Census Bureaus 2024 Current Population Survey (CPS), September 2023 Volunteering and Civic Life Supplement data from the CPS, and the 2025 KFF Benchmarking Survey with ABS and prepaid cell phone samples

Results from clinical trials of semaglutide show that semaglutide is safe and does not cause or increase the risk of cancer in humans